Filter
1705
Filtered Results: 1705
Text search:
CD4
Featured
Recommendations
119
New Publications
457
Language
Document type
No document type
1208
Guidelines
228
Studies & Reports
140
Manuals
43
Fact sheets
30
Training Material
23
Strategic & Response Plan
20
Infographics
8
Brochures
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
90
South Africa
53
Kenya
50
Tanzania
48
Latin America and the Carribbean
40
Zambia
35
Malawi
31
Paraguay
31
Uganda
30
Rwanda
27
Ethiopia
26
Nepal
25
Senegal
25
Ukraine
24
Western and Central Europe
24
Nigeria
22
Lesotho
21
Global
21
Russia
21
Namibia
21
Mozambique
20
Africa
20
Argentina
20
Eastern Europe
19
Zimbabwe
18
Indonesia
18
Asia
17
Brazil
16
Congo, Democratic Republic of
15
Cambodia
14
Venezuela
14
Colombia
12
Ghana
12
Liberia
11
Myanmar / Burma
11
Sierra Leone
10
Albania
9
Burkina Faso
9
Germany
9
Botswana
9
Haiti
8
Bolivia
8
Benin
7
Cameroon
7
Philippines
7
Bangladesh
7
Ecuador
7
Peru
6
Madagascar
6
Eswatini/ Swaziland
6
Tajikistan
5
Armenia
5
South–East Asia Region
5
Georgia
5
El Salvador
4
North America
4
Central African Republic
4
Estonia
3
Middle East and North Africa
3
East and Southern Africa
3
Vietnam
3
Moldova
3
Angola
3
Pakistan
3
North Macedonia
2
Thailand
2
Kazakhstan
2
Chile
2
Syria
2
Afghanistan
2
Guinea
2
USA
2
West and Central Africa
2
Southern Africa
2
Sudan
2
Yemen
2
Romania
2
South Sudan
2
Gambia
1
Laos
1
Niger
1
Uzbekistan
1
Italy
1
Eastern Europe and Central Asia
1
Belgium
1
Portugal
1
Spain
1
Belarus
1
Sri Lanka
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
378
Studies & Reports
137
Guidelines
101
Capacity Building
72
HIV & STI
67
Statistics
60
Women & Child Health
59
COVID-19
53
TB
47
Policies
40
Drugs & Medical Equipment
26
Community Health
22
Pediatrics
20
Demograhic Health Surveys DHS
19
Paediatrics
15
Hepatitis
14
Reproductive Health
13
Communicable Diseases
9
Countries
9
Other
8
Information, Education and Communication (IEC)
7
Humanitarian Crisis
7
Women & Child Health
7
Non-communicable Diseases
7
Bacteriology
6
Humanitarian Aid
6
Maternal & Child Health
6
Communicable Diseases
6
Gynaecology & Obstetrics
6
Disease Prevention & Control
6
Clinical Training
5
Under-5 nutrition
5
General Guidelines
5
MPOX - Monkeypox
5
Chagas
5
Clinical Guidelines
5
Disabilities
5
Primary Health Care
5
Child Health
4
Vector Control
4
Community Health
4
Virology
4
Public Health
4
Health Systems
4
Neonatal Care
4
Family Planning
3
Buruli Ulcer
3
Dermatology
3
Training Manuals
3
Immunization
3
NTDs & Others
3
Maternal Health
3
Dengue
3
Leishmaniasis
3
Age & Elderly
3
Dental & Eye Care
2
Disaster Preparedness
2
Palliative Care
2
Vaccine-preventable Diseases
2
Diarrhoeal Disease/Cholera
2
Medical Devices & Equipment
2
Palliative Care
2
Quality Control & Assurance
2
General Guidelines
2
Digital Health
1
Rabies
1
Public Health
1
Helminthiasis
1
Onchocerciasis
1
Schistosomiasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
Cervical Cancer
1
IEC Material
1
NCD
1
Child protection
1
Yellow Fever
1
Mental Health
1
WASH
1
Diarrhoea
1
Respiratory Infections
1
Surgery & Anaesthesia
1
COPD/Asthma
1
Needs Assessment
1
Laboratory Quality Assurance
1
Malaria
1
Key Resources
1
Physiotherapy & Rehabilitation
1
Pharmacy & Technologies
1
Food Security & Nutrition
1
Toolboxes
Reports & Studies
109
Eastern Europe and central Asia
77
Children & Adolescents
60
Country specific documents
41
TB/HIV Coinfection
38
Treatment & Prevention
35
Clinical Aspects, Treatment & Prevention
31
Clinical Aspects
27
Detection & Diagnosis
27
Antiretroviral Treatment ART
27
HIV in Key Populations
27
Adults
25
Prevention & Control
23
Latin America & the Carribean
22
Treatment Guidelines HIV
20
General
20
Drug resistant TB
18
HIV testing & services
17
HIV
16
ART Drug Resistance
15
General Reports
15
Opportunistic Infections
15
Policies
14
Clinical Guidelines
14
Asia and Pacific
14
Policies and guidelines
14
Co-Morbidities (except TB)
14
Universal Health Coverage UHC and 90-90-90 Strategy
13
Women
13
Training
13
Children
12
TB/HIV
12
Prevention of mother-to-child transmission (PMTCT)
12
HIV and coinfection
12
Testing Guidelines
12
Laboratory
11
Inactivated COVID-19 Vaccines
11
HIV service delivery
11
Health Worker
10
Clinical Guidelines
10
Epidemiology
10
Access to treatment and laboratory
9
TB/HIV Global
9
Reports & Studies Children HIV
9
Policies & Strategies
8
Childhood TB
8
Transgender People
8
Handbooks & Manuals
8
Midwives
8
HIV &TB
8
TB & Prisoners
8
Research & Access
8
Lobby and Advocacy
8
Eastern and Southern Africa
8
Vaccines & Immunization
7
HIV testing & disclosure
7
Others
7
Global
7
Adherence
7
Discrimination & Stigma
7
Global Impact: Socio-economic, health services, TB & HIV
7
Biontech/Pfizer Comirnaty
7
Argentina
7
HIV surveillance
6
Ukraine
6
South Africa
6
IEC Materials
6
Reports
6
Russia
6
HIV and COVID-19
6
Nurses
6
MPOX - Monkeypox
6
Community Worker
6
Germany
6
HIV / AIDS
6
Male Circumcision
5
HIV in Children and mental health
5
TB & Drug Abuse
5
Laboratory
5
Drug resistance
5
Rwanda
5
Immunization Guidelines
5
Community Health Workers CHW
5
Colombia
5
Essential Medicines & Devices Lists
5
Pharmacy Practice
5
Clinical Aspects & Diagnostics
5
Studies & Reports
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
Prophylactic Treatment
5
Eastern Europe & Central Asia
5
Kenya
5
Prisoners
5
SEAR (South-east Asia Region)
5
Drugs
4
People who injecting Drugs
4
Clinical aspects
4
For Health Worker
4
COVID-19
4
Other Countries
4
Health Care In Conflict Settings
4
Vector control
4
Romania
4
General Aspects
4
Malawi
4
AmR (Region of Americas)
4
TB
4
Surveillance
3
Hepatitis
3
Men who have sex with men (MSM)
3
Children/Adolescents Mental Disorders
3
Country Guidelines
3
HIV / AIDS
3
Paediatrics
3
Moderna
3
Vaxzevria (Astra Zeneca)
3
Covaxin
3
Primary Care
3
Brazil
3
El Salvador
3
Booster Doses
3
Pediatrics
3
Women & Maternal Health
3
Clinical Aspects & Diagnostics
3
Nutrition
3
Others
3
Africa
2
Outbreak Prevention & Control
2
Behaviour Change/Life Skill Education
2
Biosafety
2
Prevention Guidelines
2
Children
2
Dengue
2
Namibia
2
Public Health
2
Orphans & vulnerable children
2
Communication & Training
2
TB
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Prophylaxis
2
TB & Other Vulnerable Populations
2
Health & Refugee
2
Laboratory
2
Sex Worker
2
Ethiopia
2
Context & Facts, Travel Advice
2
COVID-19
2
Training, others
2
Protection of Vulnerable Groups
2
RCCE Guides & Manuals
2
TB/COVID-19
2
SARS-CoV-2 Variants
2
Health Promotion
2
Latin America
2
Overview
2
Peru
2
Chile
2
Essential Medicines
2
Zoonoses
2
MPOX - Monkeypox
2
Best Practice Examples
2
Chagas
2
Information & Education Material (IEC)
2
Overview, Studies & Reports
2
Onchocerciasis
2
General Information & Methodology
2
Prevention & Strategies
2
Prevention & Strategies
2
General
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
Tuberculosis
2
Uganda
2
Epidemiology
2
Universal Health Coverage & Primary Health Care
2
Disability Rights & Convention
1
Communication & Social Mobilisation
1
Gynaecology / Obstetrics
1
Assessment & Studies
1
HIV support organizations
1
Surveillance
1
Moldova
1
Azerbaijan
1
Policies & Strategies
1
Yellow Fever
1
Influenza Prevention & Control
1
Vaccination
1
Clinical Guidelines
1
Physiotherapy & Rehabilitation
1
Zambia
1
WPRO (Western Pacific Region)
1
South Sudan
1
Substance Use Disorders, Others
1
Humanitarian Settings
1
Germany
1
Inclusion
1
Latin America
1
Opoids
1
Wheelchair Service and Management
1
Sexually Transmitted Infections
1
Eastern Europe
1
Hepatitis
1
Physiotherapy & Rehabilitation
1
Latin America
1
Vaccination
1
SOPs
1
Mozambique
1
Human Rights
1
Epilepsy
1
Belarus
1
Key Resources
1
International
1
IEC Substance Use Disorders
1
Communication & Training
1
DR Congo
1
Treatment Guidelines
1
Clinical Aspects
1
Diagnostics & Laboratory Guidance
1
For General Public & Community
1
For Pregnant Women
1
Clinical Guidelines
1
Human Rights
1
Scientific & Research Studies
1
Gender Aspects
1
General Background
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Tips & Best Practice Examples
1
Vaccination & Strategy
1
Access & Strategy
1
Communication Material
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Others
1
Studies & Reports
1
Advocacy & Communication
1
Estonia
1
Ecuador
1
Pharmacy Management
1
Supply Chain & Store Management
1
Quality Assurance
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
Epilepsy
1
Guidelines & Manuals
1
Information Refugees Ukraine
1
General
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Information & Education Material (IEC)
1
Leptospirosis
1
West and central Africa
1
General Information
1
Health Financing Toolbox
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
General
1
Clinical Guidelines
1
Botswana
1
Neurological Disorders
1
Ghana
1
General
1
Assistive devices & technologies
1
Protection
1
Assessment & Response
1
Regional Reports & Guidelines, others
1
Malnutrition
1
Policy
1
Regions
1
For Community Health Workers
1
Diarrhoea
1
Albania
1
Assessment & Response
1
Dengue Prevention & Control
1
Reproductive Health
1
Vision Loss & Blindness
1
Nigeria
1
Tobacco
1
Tajikistan
1
Western & Central Europe
1
South-east Asia Region
1
Paediatrics
1
Preparedness & Prevention
1
Global Health Financing
1
Depression
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Certes, au Sénégal la révision périodique tous les deux ans de la Liste Nationale des Médicaments et Produits Essentiels (LNMPE) est une tradition depuis 1990. La présente liste de Médicaments et Produits Essentiels par niveaux de soins est la septième édition.
Cette sélection soigneuse...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
La Stratégie et plan d’action sur la promotion de la santé dans le contexte des objectifs de développement
durable 2019-2030 cherche à renouveler la promotion de la santé grâce à des interventions de nature sociale,
politique et technique, en agissant sur les déterminants sociaux de la s...
This Strategy and Plan of Action on Health Promotion within the Context of the Sustainable Development
Goals 2019-2030 seeks to renew health promotion (HP) through social, political, and technical actions,
addressing the social determinants of health (SDH), he conditions in which people are born, ...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
he Pan American Health Organization (PAHO) would like to thank the group that developed these guidelines for the tremendous work, quick response, and commitment they demonstrated in this process. We would like to especially recognize the following doctors: Roberto Chuit, Jaime Altcheh, Alejandro Luq...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Paraguay muestra avances en el compromiso asumido, de avanzar hacia la Salud Uni¬versal. La experiencia ha demostrado que el proceso puede acelerarse cuando existe un fuerte involucramiento social. En este marco se realizó un llamado a los líderes del MSPYBS, la sociedad civil y público en gener...
The report brings a new dimension to long-term thinking about the future approach to these diseases. For the fi rst time, it sets out financing needs, options, and targets for meeting WHO Roadmap goals by 2020, but also for reaching universal coverage of all people in need by 2030. Th e report makes...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
